DDW 2022 Conference Coverage
Playback speed
10 seconds
Early Experience of Ustekinumab for Treatment of Moderate-To-Severe Inflammatory Bowel Disease in Patients Post-Liver Transplant
By
DDW 2022 Conference Coverage
FEATURING
Pooja Magavi
By
DDW 2022 Conference Coverage
FEATURING
Pooja Magavi
11 views
July 8, 2022
Comments 0
Login to view comments.
Click here to Login
Videos